For: | Qiu B, Zhao MF, Yue ZD, Zhao HW, Wang L, Fan ZH, He FL, Dai S, Yao JN, Liu FQ. Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension. World J Gastroenterol 2015; 21(43): 12439-12447 [PMID: PMC4649127 DOI: 10.3748/wjg.v21.i43.12439] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i43/12439.htm |
Number | Citing Articles |
1 |
Christine Cannataci, Biagio Cimo’, Giuseppe Mamone, Fabio Tuzzolino, Mario D’Amico, Kelvin Cortis, Luigi Maruzzelli, Roberto Miraglia. Portal vein puncture-related complications during transjugular intrahepatic portosystemic shunt creation: Colapinto needle set vs Rösch-Uchida needle set. La radiologia medica 2021; 126(11): 1487 doi: 10.1007/s11547-021-01404-1
|
2 |
Anna Fichtl, Thomas Seufferlein, Eugen Zizer. Risks and benefits of TIPS in HCC and other liver malignancies: a literature review. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-03047-0
|
3 |
Yan Zhang, Da-Feng Mao, Mei-Wu Zhang, Xiao-Xiang Fan. Clinical value of liver and spleen shear wave velocity in predicting the prognosis of patients with portal hypertension. World Journal of Gastroenterology 2017; 23(45): 8044-8052 doi: 10.3748/wjg.v23.i45.8044
|
4 |
Jiaywei Tsauo, Jun Tie, Hui Xue, Jian-Bo Zhao, Jian-Jun Li, Zhu-Ting Fang, Wu-Hua Guo, Xiao Li. Transjugular Intrahepatic Portosystemic Shunt Creation for the Prevention of Gastric Variceal Rebleeding in Patients with Hepatocellular Carcinoma: A Multicenter Retrospective Study. Journal of Vascular and Interventional Radiology 2021; 32(7): 963 doi: 10.1016/j.jvir.2021.04.005
|
5 |
David M. Ruohoniemi, Bedros Taslakian, Eric A. Aaltonen, Ryan Hickey, Amish Patel, Jeremy C. Horn, Matthew Chiarello, Meredith McDermott. Comparative Analysis of Safety and Efficacy of Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma in Patients with and without Pre-Existing Transjugular Intrahepatic Portosystemic Shunts. Journal of Vascular and Interventional Radiology 2020; 31(3): 409 doi: 10.1016/j.jvir.2019.11.020
|
6 |
Dalia Mitraitė, Paula Zibalytė, Erikas Strupeikis, Sigita Gelman. ULTRAGARSINIO TYRIMO REIKŠMĖ VERTINANT TRANSJUGULINIO INTRAHEPATINIO PORTOSISTEMINIO ŠUNTO (TIPS) PROCEDŪROS VEIKSMINGUMĄ IR KOMPLIKACIJŲ RIZIKĄ PO PROCEDŪROS. Medicinos teorija ir praktika 2016; 22(2): 127 doi: 10.15591/mtp.2016.018
|
7 |
Jenny Yan, Xiaohan Ying, Anuj Malhotra, Adam Talenfeld, Resmi Charalel, Kyungmouk Steve Lee, David Trost, Andrew Kesselman. Safety and Efficacy of Microwave Ablation for Hepatocellular Carcinoma in the Setting of Transjugular Intrahepatic Portosystemic Shunt. CardioVascular and Interventional Radiology 2022; 45(5): 578 doi: 10.1007/s00270-021-03012-y
|
8 |
Yan Chen, Xuemei Ma, Xuefeng Zhang, Jing Luo, Linjing An, Yu Zhang, Xiujuan Chang, Zheng Dong, Wei Zhang, Huifang Kong, Jun Zhao, Huiguo Ding, Fuquan Liu, Yongping Yang. Prevention of variceal rebleeding in cirrhotic patients with advanced hepatocellular carcinoma receiving molecularly targeted therapy: a randomized pilot study of transjugular intrahepatic portosystemic shunt versus endoscopic plus β-blocker. Hepatology International 2022; 16(6): 1379 doi: 10.1007/s12072-022-10388-7
|
9 |
Shi-Hua Luo, Jian-Guo Chu, He Huang, Ke-Chun Yao. Safety and efficacy of transjugular intrahepatic portosystemic shunt combined with palliative treatment in patients with hepatocellular carcinoma. World Journal of Clinical Cases 2019; 7(13): 1599-1610 doi: 10.12998/wjcc.v7.i13.1599
|
10 |
Ketan Y. Shah, Ron C. Gaba. Transjugular Intrahepatic Portosystemic Shunt Creation in Patients with Hepatocellular Carcinoma and Bleeding Gastric Varices: More Data, More Questions. Journal of Vascular and Interventional Radiology 2021; 32(7): 971 doi: 10.1016/j.jvir.2021.05.011
|
11 |
Junyang Luo, Mingan Li, Chun Wu, Duo Zhu, Haofan Wang, Mingsheng Huang, Zaibo Jiang. Transjugular intrahepatic portosystemic shunt versus endoscopic therapy for prevention of variceal rebleeding in patients with hepatocellular carcinoma meeting the Milan criteria. European Journal of Gastroenterology & Hepatology 2021; 33(3): 436 doi: 10.1097/MEG.0000000000001750
|
12 |
Daniele Balducci, Michele Montori, Federico De Blasio, Alessandro Di Bucchianico, Maria Eva Argenziano, Gianluca Svegliati Baroni, Emidio Scarpellini. The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in Treating Portal Hypertension in Patients with Hepatocellular Carcinoma. Medicina 2023; 59(6): 1150 doi: 10.3390/medicina59061150
|
13 |
Hai-lin Lu, Fei-fei Xuan, Yao-chang Luo, Xiao Qin. Efficacy and safety of transjugular intrahepatic portosystemic shunt combined with transcatheter embolization/chemoembolization in hepatocellular carcinoma with portal hypertension and arterioportal shunt. Abdominal Radiology 2021; 46(11): 5417 doi: 10.1007/s00261-021-03214-5
|
14 |
He Zhao, Jiaywei Tsauo, Xiaowu Zhang, Tao Gong, Jinggui Li, Xiao Li. Transjugular intrahepatic portosystemic shunt creation for portal hypertension in patients with hepatocellular carcinoma: A systematic review. International Journal of Gastrointestinal Intervention 2018; 7(3): 167 doi: 10.18528/gii180026
|
15 |
Hae Lim Lee, Sung Won Lee. The role of transjugular intrahepatic portosystemic shunt in patients with portal hypertension: Advantages and pitfalls. Clinical and Molecular Hepatology 2022; 28(2): 121 doi: 10.3350/cmh.2021.0239
|
16 |
Blanca Norero, Jaume Bosch, Annalisa Berzigotti, Susana G. Rodrigues. Transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma: A systematic review. United European Gastroenterology Journal 2023; 11(8): 733 doi: 10.1002/ueg2.12454
|
17 |
J. Tsauo, S.Y. Noh, J.H. Shin, D.I. Gwon, K. Han, J.M. Lee, U.B. Jeon, Y.H. Kim. Retrograde transvenous obliteration for the prevention of variceal rebleeding in patients with hepatocellular carcinoma: a multicentre retrospective study. Clinical Radiology 2021; 76(9): 681 doi: 10.1016/j.crad.2021.05.011
|
18 |
Rumei Yang, Yin Xu, Weiwei Hou, Ling Wang, Shuping Xiao, Chunhong Li, Hongyan Shao, Xiaoyan Fei, Zhongmin Wang. Transitional Care for Patients With Portal Hypertension: A Multicenter Study of Intervention for Post-TIPS Patients. Clinical Nursing Research 2023; 32(4): 785 doi: 10.1177/10547738221112746
|
19 |
Z.-X. Chen, Z.-K. Qiu, G.-B. Wang, G.-S. Wang, W.-W. Jiang, F. Gao. Safety and effectiveness of transjugular intrahepatic portosystemic shunt in hepatocellular carcinoma patients with portal hypertension: a systematic review and meta-analysis. Clinical Radiology 2023; 78(3): 209 doi: 10.1016/j.crad.2022.09.126
|
20 |
Suprabhat Giri, Ankita Singh, Swati Das, Kateryna Strubchevska, Taraprasad Tripathy, Ranjan Kumar Patel, Marko Kozyk, Akash Roy. Efficacy and safety of transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma—A systematic review and meta-analysis. Indian Journal of Gastroenterology 2024; 43(6): 1121 doi: 10.1007/s12664-024-01646-7
|
21 |
Bin Qiu, Kai Li, Xiaoqun Dong, Fu-Quan Liu. Transjugular Intrahepatic Portosystemic Shunt for Portal Hypertension in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. CardioVascular and Interventional Radiology 2017; 40(9): 1372 doi: 10.1007/s00270-017-1655-8
|